Skip to content
Search

Latest Stories

NHS approves new daily pill for endometriosis treatment in the UK

This new treatment represents a positive development in endometriosis care

NHS Greenlights New Daily Pill for Endometriosis Relief

This new pill can be taken at home

iStock

A new daily pill, relugolix-estradiol-norethisterone, designed to treat endometriosis, has been approved for use across England’s NHS. This medication provides a convenient and effective alternative to traditional treatments, offering relief for women suffering from this painful condition.

A Breakthrough in Endometriosis Care


Endometriosis, a condition where tissue similar to the lining of the womb grows elsewhere in the body, affects around one in ten women of reproductive age. Symptoms include severe menstrual pain, discomfort during bowel movements, and issues with fertility. Women in the UK typically wait up to nine years for a diagnosis. Current treatments often involve hormone injections administered at clinics, which can initially worsen symptoms.

The newly approved pill, however, can be taken at home and combines multiple hormones into a single dose. This makes it faster-acting and more convenient than injectable treatments, offering greater control for women managing the condition.

Empowering Women with More Options

The National Institute for Health and Care Excellence (NICE) had initially rejected the treatment but later approved it for use, with around 1,000 women expected to benefit each year. Endometriosis UK welcomed the approval, emphasizing the importance of providing women with more choices in their treatment.

Helen Knight from NICE hailed the pill as a “step-change” in endometriosis care, highlighting its potential to reduce the need for frequent hospital visits, thereby easing pressure on NHS services. Dr. Sue Mann, NHS’s national clinical director for women’s health, noted the pill's ability to give women more control over their health, allowing treatment to be managed at home.

More For You

sugary drinks and ice cream

Researchers from the UK and US analysed data from American households between 2004 and 2019

iStock

Global warming may drive higher consumption of sugary drinks and ice cream, study warns

Highlights:

  • Hotter days linked to greater intake of sugary drinks and frozen desserts
  • Lower-income households most affected, research finds
  • Climate change could worsen health risks linked to sugar consumption
  • Study based on 15 years of US household food purchasing data

Sugary consumption rising with heat

People are more likely to consume sugary drinks and ice cream on warmer days, particularly in lower-income households, according to new research. The study warns that climate change could intensify this trend, adding to health risks as global temperatures continue to rise.

Sugar consumption is a major contributor to obesity, diabetes, and cardiovascular disease, and has surged worldwide in recent decades. The findings, published in Nature Climate Change, suggest that rising heat could be nudging more people towards high-sugar products such as soda, juice and ice cream.

Keep ReadingShow less
Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less